Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain
about
Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor geneAndrogen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiationMerlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleusStructural basis of cargo recognition by the myosin-X MyTH4-FERM domainStructure of dimerized radixin FERM domain suggests a novel masking motif in C-terminal residues 295-304Mouse models of neurofibromatosis 1 and 2.Structure of the active N-terminal domain of Ezrin. Conformational and mobility changes identify keystone interactionsStructural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex.Structural Basis for CD44 Recognition by ERM ProteinsStructural Basis of Tumor Suppressor in Lung Cancer 1 (TSLC1) Binding to Differentially Expressed in Adenocarcinoma of the Lung (DAL-1/4.1B)Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressorStructural Basis of the Binding of Merlin FERM Domain to the E3 Ubiquitin Ligase Substrate Adaptor DCAF1Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 functionMolecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering studyMerlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survivalCrystal structure of the FERM domain of focal adhesion kinase.NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.FERM domain interaction promotes FAK signaling.Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function.Fluorescence resonance energy transfer analysis of merlin conformational changes.p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathwayFERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.Membrane recognition and targeting by lipid-binding domains.Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain.Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.Topographical significance of membrane skeletal component protein 4.1 B in mammalian organs.Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencingStructural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.Novel mutation c.980_983delATTA compound with c.986C>A mutation of the FRMD7 gene in a Chinese family with X-linked idiopathic congenital nystagmusMerlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex.Merlin: the wizard requires protein stability to function as a tumor suppressor.Merlin, the NF2 gene product.Molecular insights into NF2/Merlin tumor suppressor function.Hippo-YAP signaling pathway: A new paradigm for cancer therapy.Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.Schwannomas exhibit distinct size-dependent gene-expression patterns.Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.
P2860
Q21283962-935C2926-A805-4342-ADEA-9EB96A5BA335Q24296691-D77AA50A-8E54-44EE-9EE0-213C2F4E1903Q24300692-4E7173DF-C93C-40CC-8E8B-E3D0A3CB248BQ24305586-B58E2032-4529-4051-9D6E-36A43467A613Q24313074-09567175-A9F8-4EAD-A3B2-D7B40B6490D3Q24682869-630A11A4-3985-4490-8816-DB430A4C1CD7Q27639959-18CD4929-B250-4FC1-AF7D-20D515E6C523Q27640373-BDD8344F-11C3-4833-9060-801F23583A10Q27651819-54E371F0-010B-492C-8240-4BB8AE305768Q27666177-CD2C1B30-ABB2-4BE0-982A-AFE5C1BA6356Q27675130-F5DEC1AF-CF70-4F20-A6FF-572D804C0DC0Q27683013-D246B20A-7ED6-449A-918A-791D0D0A046DQ27690668-964D72B2-E432-4B47-AE91-42FEA7492FF3Q28241032-D428E669-3482-4E47-952B-82337A2D70F1Q28283076-003D5076-30BA-49FE-91E9-606AE33114B0Q30160113-74E6217F-7F31-46FD-8AE8-CFF31B7D8F2FQ30440530-64571585-13A3-4D0A-9307-E6F65B6D223FQ30449206-3FD356A8-5EED-4671-A1E4-2E71D525B2E3Q30474083-1581620E-BED1-408C-A5E2-26215E7A931AQ33240466-3D645CBF-39FA-492A-B526-D7B8D8FD61B6Q33558192-AF21FC76-D5B3-4871-89B6-1136A4C379EAQ33745071-BECF001D-C192-4B24-9230-28474C8078B8Q34479368-31CBEFA1-B751-4C2F-95DF-FFC74FB991C6Q35096540-370790C2-0BAA-4539-8E55-BC57DE63B40FQ35609309-2821C248-311A-4DDF-B380-2E0333B3CACDQ35633077-39E9B63D-DB6F-4A3B-8FBD-56E7F3DEB92AQ35880377-8E46DB43-9717-4974-A3E0-EA39011CEFC6Q36165142-BF953CF5-FB75-4474-AF6E-0DF71906C60BQ36483405-264C4660-9C9E-4192-8D07-C2A3479282E3Q36506124-A5C92458-BD02-40E7-A482-E10E610B6E76Q36927809-C7BE052F-3177-475C-A46F-04CB7A5FFEBFQ37432747-C5B0ED62-97C8-435F-BB2C-ABD135AED9C9Q38023101-1F1AF4AA-8B1A-422B-9F54-EDEFE684B063Q38105985-73EF63B1-6283-497B-A216-33C831C96002Q38204110-303B0089-173C-452A-A199-7BA59DDF724FQ38231786-88F03E1F-6860-4219-A2AD-E866C6230B76Q38736783-185A3327-DFA5-4130-83EB-85DCE836AB8CQ38995513-041D2C34-35FF-48B4-B63E-2C9B28FE98F7Q39739259-E7D4FE5D-D305-48E6-B8B8-6A2F3B158893Q40235602-E31F6BBB-56E9-4305-8F04-0A4431126A7B
P2860
Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Structural basis for neurofibr ...... ture of the merlin FERM domain
@ast
Structural basis for neurofibr ...... ture of the merlin FERM domain
@en
Structural basis for neurofibr ...... ture of the merlin FERM domain
@nl
type
label
Structural basis for neurofibr ...... ture of the merlin FERM domain
@ast
Structural basis for neurofibr ...... ture of the merlin FERM domain
@en
Structural basis for neurofibr ...... ture of the merlin FERM domain
@nl
prefLabel
Structural basis for neurofibr ...... ture of the merlin FERM domain
@ast
Structural basis for neurofibr ...... ture of the merlin FERM domain
@en
Structural basis for neurofibr ...... ture of the merlin FERM domain
@nl
P2093
P2860
P356
P1476
Structural basis for neurofibr ...... ture of the merlin FERM domain
@en
P2093
Azusa Seto
Keisuke Hamada
Nobuo Maita
Sachiko Tsukita
Shoichiro Tsukita
Toshio Hakoshima
Toshiyuki Shimizu
P2860
P304
P356
10.1074/JBC.M109979200
P407
P577
2002-03-22T00:00:00Z